维普期刊资源整合服务平台（V6.5）

261篇 您的检索式：作者名="Cobleigh"

选中清除导出查看参考文献查看引证文献引用追踪共14页首页上一页第1页下一页末页 /14 跳转

	题名	作者	年代	出处	被引量
1	The basal subtype of breast carcinomas may represent the group of breast tumors that could benefit from EGFR-targeted therapies显示文摘	Kalliopi P. Siziopikou Melody Cobleigh	2006	The Breast2006，，1：	2
2	Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2- overexpressing netastatic breast cancer显示文摘	Vogel EL Cobleigh MA Tripathy D	2002	J Clin Oncol2002，20，3：	1
3	Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-over- expressing metastatic breast cancer 显示文摘	Vogel CL Cobleigh MA Tripathy D	2002	J Clin Oncol2002，20，3：	1
4	Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease显示文摘	Cobleigh MA Vogel CL Tripathy D	1999	JClin Oncol1999，17，9：	1
5	Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer显示文摘	Vogel CL Cobleigh MA Tripathy D		0，，03：	1
6	Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer 显示文摘	Vogel CL Cobleigh MA Tripathy D	2002	J Clin Oncol2002，20，3：	1
7	First line, single-agent Herceptin (trastuzumab) in metastatic breast cancer : a pre-liminary report显示文摘	Vogel C Cobleigh MA Tripathy D	2001	Eur J Cancer2001，37，：	1
8	Efficacy and safety of Herceptin (trastuzumab humanized anti-HER2 antibody) as a single agent in first line treatment of HER2 overexpressing metastatic breast cancer(HER2+/MBC)显示文摘	Vogel CL Cobleigh MA Trpathy D	1998	Breast Cancer Res Treat1998，50，：	1
9	The basal subtype of breast carcinomas may represent the group Of breast tumors that could benefit from EGFR-targeted therapies 显示文摘	Siziopikou Kp Cobleigh M	2007	Breast2007，16，1：	1
10	Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overex- pressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease 显示文摘	Cobleigh MA Vogel CL Tripathy D	1999	J Clin Oncol1999，17，9：	1
11	Efficacy and safety of Herceptin (humanized anti-HER2 antibody) as a single agent in 222 women with HER2 overexpression who relapsed following chemotherpy for metastatic breast cancer显示文摘	Cobleigh MA Vogel CL Tripathy D		Pro Am Soc Clin Oncol0，1，：	1
12	Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer 显示文摘	Bines J Oleske DM Cobleigh MA	1996	J Clin Oncol1996，14，5：	1
13	Efficacy and safety of tras- tuzumab as a single agent in first-line treatment of HER2-overexpress- ing metastatic breast cancer显示文摘	Vogel CL Cobleigh MA Tripathy D	2002	Journal of Clinical Oncology2002，20，3：	1
14	Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease显示文摘	Cobleigh MA Vogel CL Tripathy D	1999	J Clin Oncol1999，17，9：	1
15	The basal subtype of breast carcinomas may represent the group of breast tumors that could benefit from EGFR2 targeted therapies 显示文摘	Siziopikou KP Cobleigh M	2007	Breast2007，16，1：	1
16	Other options in the treatment of advanced breast cancer显示文摘	Cobleigh MA	2011	Semin Oncol2011，6，38：	1
17	Adjuvant endocrine therapy for breast cancer 显示文摘	Rao RD Cobleigh MA	2012	Oncology (Williston Park)2012，26，6：	1
18	FLAVERS: A finite state verification technique for software systems显示文摘	Cobleigh J M Clarke L A Osterweil L J	2002	IBM Systems Journal2002，41，1：	1
19	Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metasta-tic disease 显示文摘	Vogel CL Tripathy D	1999	J Clin Oncol1999，17，9：	1
20	First-line monotherapy in metastatic breast cancer显示文摘	Vogel CL Cobleigh MA Tripathy D	2001	Oncology2001，612，：	1

返回顶部每页显示：

共14页首页上一页第1页下一页末页 /14 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示